These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9639415

  • 1. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
    Brada SJ, de Wolf JT, Hendriks DW, Smit JW, Vellenga E.
    Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
    [Abstract] [Full Text] [Related]

  • 2. The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36- sorted bone marrow cells of myelodysplasia patients.
    Brada S, de Wolf J, Hendriks D, Esselink M, Ruiters M, Vellenga E.
    Blood; 1996 Jul 15; 88(2):505-10. PubMed ID: 8695798
    [Abstract] [Full Text] [Related]

  • 3. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation.
    de Wolf JT, Muller EW, Hendriks DH, Halie RM, Vellenga E.
    Blood; 1994 Jul 01; 84(1):59-64. PubMed ID: 7517219
    [Abstract] [Full Text] [Related]

  • 4. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M, Saito H.
    Leukemia; 1994 May 01; 8(5):833-8. PubMed ID: 7514249
    [Abstract] [Full Text] [Related]

  • 5. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 May 01; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 6. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S, Lacombe C, Dreyfus F, Mayeux P, Fontenay-Roupie M.
    Blood; 2002 Mar 01; 99(5):1594-601. PubMed ID: 11861273
    [Abstract] [Full Text] [Related]

  • 7. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
    Verbeek W, Vehmeyer K, Wörmann B, Hiddemann W.
    J Cancer Res Clin Oncol; 1995 Mar 01; 121(6):338-42. PubMed ID: 7797598
    [Abstract] [Full Text] [Related]

  • 8. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug 01; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 9. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L, Leemhuis T, Srour EF, Yang YC.
    Exp Hematol; 1992 May 01; 20(4):418-24. PubMed ID: 1373687
    [Abstract] [Full Text] [Related]

  • 10. An improved serum free system for cloning human "pure" erythroid colonies. The role of different growth factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells.
    Ratajczak J, Marlicz W, Machaliński B, Pertusini E, Czajka R, Ratajczak MZ.
    Folia Histochem Cytobiol; 1998 May 01; 36(2):55-60. PubMed ID: 9606618
    [Abstract] [Full Text] [Related]

  • 11. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro.
    von Lindern M, Zauner W, Mellitzer G, Steinlein P, Fritsch G, Huber K, Löwenberg B, Beug H.
    Blood; 1999 Jul 15; 94(2):550-9. PubMed ID: 10397722
    [Abstract] [Full Text] [Related]

  • 12. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I, Taniyama M, Toyama K, Homori M, Ishikawa K.
    Stem Cells; 1994 May 15; 12(3):329-38. PubMed ID: 7521243
    [Abstract] [Full Text] [Related]

  • 13. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
    Pierelli L, Scambia G, Menichella G, Fattorossi A, Ciarli M, Bonanno G, Battaglia A, d'Onofrio G, Benedetti Panici P, Iacone A, Mancuso S, Leone G.
    Br J Haematol; 1997 Jan 15; 96(1):55-63. PubMed ID: 9012687
    [Abstract] [Full Text] [Related]

  • 14. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG, D'Ippolito G, Bernabei PA, Caporale R, Nannini R, Mariani M, Fabbiani M, Rossi-Ferrini P, Olivotto M, Dello Sbarba P.
    Exp Hematol; 1997 Oct 15; 25(11):1187-94. PubMed ID: 9328456
    [Abstract] [Full Text] [Related]

  • 15. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M.
    Leukemia; 1997 Jun 15; 11(6):839-45. PubMed ID: 9177438
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.
    Xiao W, Koizumi K, Nishio M, Endo T, Osawa M, Fujimoto K, Sato I, Sakai T, Koike T, Sawada Ki.
    Exp Hematol; 2002 Nov 15; 30(11):1238-47. PubMed ID: 12423676
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta 1 is an inducer of erythroid differentiation.
    Krystal G, Lam V, Dragowska W, Takahashi C, Appel J, Gontier A, Jenkins A, Lam H, Quon L, Lansdorp P.
    J Exp Med; 1994 Sep 01; 180(3):851-60. PubMed ID: 7520475
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
    Su S, Mukaida N, Wang J, Zhang Y, Takami A, Nakao S, Matsushima K.
    Blood; 1997 Jul 15; 90(2):605-11. PubMed ID: 9226160
    [Abstract] [Full Text] [Related]

  • 19. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
    Sakabe H, Kimura T, Zeng Z, Minamiguchi H, Tsuda S, Yokota S, Hodohara K, Abe T, Lyman SD, Sonoda Y.
    Eur J Haematol; 1998 May 15; 60(5):297-306. PubMed ID: 9654159
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
    Brada SJ, de Wolf JT, Hendriks D, Louwes H, van den Berg E, Vellenga E.
    Leukemia; 1998 Mar 15; 12(3):340-5. PubMed ID: 9529128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.